tirzepatide eating disorder GLP-1 receptor agonists: A novel pharmacotherapy for binge (Binge eating and bulimia nervosa)? A systematic review Tirzepatide reduces appetite, food cravings

Because the syringe markings confused them, the concentration math tripped them up, and nobody gave them a clear chart to follow

And of course, many prediabetics will turn into diabetics

This version may be an option for people who cannot use FDA-approved forms of semaglutide, such as people who have allergies to certain ingredients

Fortunately, GLP1 medications are now FDA-indicated for multiple indications beyond weight management and diabetes, including: Major cardiovascular event (heart attack and/or stroke) risk reduction in adults with cardiovascular disease and overweight or obesity Metabolic dysfunctionassociated steatohepatitis (MASH) Moderate to severe obstructive sleep apnea (OSA) in adults with obesity When one medication can address multiple conditions, it simplifies care and reduces polypharmacy

Still struggling to eat at all